https://bullishdaily.com/news/biotech-ma-surge-300b-patent-cliff-impact-analysis
Biotech M&A Surge Accelerates Ahead of $300B Patent Cliff, Reshaping Industry Landscape -...
m apatent cliffbiotechsurgeahead
https://www.pharmaceutical-technology.com/analyst-comment/thinning-revenues-eliquis-patent-cliff/
Thinning revenues: inside the $14bn Eliquis patent cliff - Pharmaceutical Technology
Apr 30, 2026 - With $14.bn in projected revenue losses over six years, the Eliquis loss-of-exclusivity event is set to become one of the most consequential patent cliffs in...
patent cliffpharmaceutical technologythinningrevenuesinside
https://www.epmscientific.com/en-ae/industry-insights/hiring-advice/the-patent-cliff-is-here-is-your-life-sciences-talent-strategy-ready
Patent Cliff Talent Crisis: Life Sciences Hiring Strategy 2025-2030
$300bn in drug revenues will lose exclusivity by 2030. Learn which life sciences roles are hardest to hire and how to align your talent strategy with market...
patent clifflife scienceshiring strategytalentcrisis
https://gabionline.net/generics/research/Patent-cliff-winners-and-losers
Patent cliff winners and losers
During 2011 and 2012 a whole host of patents have expired on many blockbuster drugs. In fact it was estimated that in 2012 US$33 billion of sales w...
winners and loserspatent cliff
https://www.q1productions.com/tag/patent-cliff/
Patent Cliff Archives - Q1 Productions
patent cliffarchivesproductions
https://dailysanfranciscobaynews.com/bayer-ceo-invoice-anderson-says-pharma-rebuild-progressing-however-patent-cliff-a-priority-san-francisco-enterprise-instances-the-enterprise-journals/
Bayer CEO Invoice Anderson says pharma rebuild 'progressing,' however patent cliff a priority - San...
patent cliffbayerceoinvoiceanderson